Published date: 19 October 2020

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 23 December 2020, 12am

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region

Value of contract

£1

Procurement reference

BIP535012293

Published date

19 October 2020

Closing date

23 December 2020

Closing time

12am

Contract start date

1 April 2021

Contract end date

30 June 2022

Contract type

Supply contract

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

COVID-19 requires over 500,000 'at risk' people in the UK to be protected via antibody prophylaxis as they are unlikely to benefit from a vaccine. Demand for antibody prophylaxis is estimated at up to 1.5million 1g doses of an antibody cocktail (containing two antibodies @0.5g each) per annum. Current UK manufacturing supply chains do not have capacity to produce these levels. To secure this and ensure the UK is best placed to respond to future requirements, by assuring supply chain resilience and access, the Department is seeking to engage the market to explore how UK antibody manufacturing capability can be developed. The target is for capability to reach 1.5m 1g doses of antibody cocktail pa under Good Manufacturing Process by the end of Q2 2022.

More information

Links

About the buyer

Address

1 Victoria Street
London
SW1H 0ET
UK

Telephone

+447585992946

Email

abstender@beis.gov.uk